Patent · US Active

Compounds, compositions and methods

US10035770B2 · kind B2 · utility

23Cited by

49References

19Claims

0Family size

Assignee

CYTOKINETICS, INC. · US

Inventors

Bradley P. Morgan · Moraga, US
Alex Muci · South San Francisco, US
Pu-Ping Lu · Foster City, US
Erica Anne Kraynack · South San Francisco, US
Todd Tochimoto · Foster City, US
David J. Morgans, Jr. · Los Altos, US

Key dates

Filing date	Apr 6, 2017
Grant date	Jul 31, 2018
Priority date	—
Expiry date	Apr 6, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Certain substituted urea derivatives selectively modulate the cardiac sarcomere, for example by potentiating cardiac myosin, and are useful in the treatment of systolic heart failure including congestive heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.